Tucker, Robin D.
Ciofoaia, Victor
Nadella, Sandeep
Gay, Martha D.
Cao, Hong
Huber, Matthew
Safronenka, Anita
Shivapurkar, Narayan
Kallakury, Bhaskar
Kruger, Annie J.
Kroemer, Alexander H. K.
Smith, Jill P. http://orcid.org/0000-0002-0835-4802
Funding for this research was provided by:
American Gastroenterological Association
Ruesch Foundation
National Cancer Institute (CA051008)
National Heart, Lung, and Blood Institute (TL1-TR001431)
Article History
Received: 13 March 2019
Accepted: 3 July 2019
First Online: 11 July 2019
Compliance with Ethical Standards
:
: Jill P. Smith has intellectual property on the use of CCK receptor antagonists in NASH. Sandeep Nadella and Jill P. Smith are co-inventors on a pending patent for proglumide and fibrosis. None of the other authors have conflicts to report.
Free to read: This content has been made available to all.